There are 2949 resources available
556P - Initial clinical experience of lucitanib + nivolumab in advanced metastatic solid tumours: Data from the phase Ib/II LIO-1 study (CO-3810-101; NCT04042116)
Presenter: Erika Hamilton
Session: E-Poster Display
Resources:
Abstract
557P - Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations: The phase Ib SAKK 19/16 trial
Presenter: Patrizia Froesch
Session: E-Poster Display
Resources:
Abstract
558P - A phase I study of rebastinib and carboplatin in patients with metastatic solid tumours
Presenter: Filip Janku
Session: E-Poster Display
Resources:
Abstract
559P - Phase Ib study of CC-90011 plus etoposide and cisplatin (EP) in patients with first-line extensive-stage (ES) small cell lung cancer (SCLC)
Presenter: Luis Paz-Ares
Session: E-Poster Display
Resources:
Abstract
560P - Safety and efficacy of Debio 1143, an antagonist of inhibitor of apoptosis proteins (IAPs), in combination with nivolumab in a phase Ib/II trial in patients (pts) failing prior PD-1/PD-L1 treatment
Presenter: Analia Azaro Pedrazzoli
Session: E-Poster Display
Resources:
Abstract
561P - Phase Ib study of ribociclib (R) + trametinib (T) in patients (pts) with metastatic/advanced solid tumours
Presenter: Patricia LoRusso
Session: E-Poster Display
Resources:
Abstract
562P - Target engagement and clinical safety of CB-103, a first-in-class small molecule inhibitor of the NOTCH transcription complex
Presenter: Analia Azaro Pedrazzoli
Session: E-Poster Display
Resources:
Abstract
563P - First-in-class CD13-targeted tissue factor tTF-NGR in patients with recurrent or refractory malignant tumours: Safety and pharmacokinetic results of a phase I study
Presenter: Christoph Schliemann
Session: E-Poster Display
Resources:
Abstract
564P - Updated results of a phase I study of Felezonexor (SL-801), a novel XPO-1 reversible inhibitor, in patients with relapsed/refractory solid tumours
Presenter: Judy Wang
Session: E-Poster Display
Resources:
Abstract
565P - Selinexor in combination with topotecan in patients with advanced or metastatic solid tumours: Results of an open label, single-center, multi-arm phase Ib study
Presenter: Kyaw Thein
Session: E-Poster Display
Resources:
Abstract